Combined 18F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 759-763

  Guido, Alessandra ^a   Fuccio, Lorenzo ^a   Rombi, Barbara ^a   Castellucci, Paolo ^a   Cecconi, Agnese ^a   Bunkheila, Feisal ^a   Fuccio, Chiara ^a   Spezi, Emiliano ^a   Angelini, Anna Lisa ^a   Barbieri, Enza ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

18F FDG PET; 18F fluorodeoxyglucose positron emission tomography; Computed tomography; Gross tumor volume; GTV; Head and neck cancer; Image fusion; PET CT; Planning target volume; PTV

Indexed keywords

BIOLOGICAL RADIATION EFFECTS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; ELECTRIC INSTRUMENT TRANSFORMERS; IMAGE FUSION; MEDICAL IMAGING; ONCOLOGY; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; RADIOTHERAPY; TARGETS; TOMOGRAPHY; TUMORS;

18F-FDG-PET; 18F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY; COMPUTED TOMOGRAPHY; GROSS TUMOR VOLUME; GTV; HEAD-AND-NECK CANCER; PET-CT; PLANNING TARGET VOLUME; PTV;

POSITRON EMISSION TOMOGRAPHY;

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTERMETHOD COMPARISON; LARYNX CANCER; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; OROPHARYNX CANCER; PARANASAL SINUS CANCER; PAROTID GLAND CANCER; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT WITHDRAWAL; TUMOR VOLUME; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; EVALUATION; HEAD AND NECK TUMOR; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59649086607     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.059     Document Type: Article

References (21)

1. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non small cell lung cancer: Mediastinal staging in the 1990s-Meta-analytic comparison of PET and CT. Radiology 213 (1999) 530-536
2. Hawighorst H., Knapstein P.G., Weikel W., et al. Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross section and histopathologic findings. Radiologe 37 (1997) 130-138
3. Gupta N.C., Tamim W.J., Graeber G.G., et al. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxiglucose imaging in lung cancer staging. Chest 120 (2001) 521-527
4. Czernin J., and Phelps M.E. Positron emission tomography scanning: Current and future applications. Annu Rev Med 53 (2002) 89-112
5. Kluetz P.G., Meltzer C.C., Villemange V.L., et al. Combined PET/CT imaging in oncology: Impact on patient management. Clin Positron Imaging 3 (2000) 223-230
6. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
7. Braams J.W., Pruim J., Freling N.J., et al. Detection of lymph node metastases of squamous-cell cancer of head and neck with FDG-PET and MRI. J Nucl Med 36 (1995) 211-216
8. Laubenbacher C., Saumweber D., Wagner-Manslau C., et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell-carcinomas. J Nucl Med 36 (1995) 1747-1757
9. Kao C.H., ChangLai S.P., Chieng P.U., et al. Detection of recurrence or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxiglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 16 (1998) 3550-3555
10. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [(18F)]fluorodeoxiglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
11. Brun E., Kjellen E., Tennvall J., et al. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24 (2002) 127-135
12. Paulino A.C., Thorstad W.L., and Fox T. Role of fusion in radiotherapy treatment planning. Semin Nucl Med 23 (2003) 238-243
13. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
14. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computed tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
15. Heron D.E., Andrade R.S., Flickinger J., et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int J Radiat Oncol Biol Phys 60 (2004) 1419-1424
16. Paulino A.C., Koshy M., Howell R., et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1385-1392
17. Wang D., Schultz C.J., Jursinic P.A., et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 143-151
18. Breen S.L., Publicover J., De Silva S., et al. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys 68 (2007) 763-770
19. Riegel A.C., Berson A.M., Destian S., et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys 65 (2006) 726-732
20. Veilt-Haibach P., Luczak C., Wanke I., et al. TNM staging with FDG-PET/CT in patients with primary head and neck cancer. Eur J Nucl Med Mol Imaging 34 (2007) 1953-1962
21. Hojgaard L., and Specht L. PET/CT in head and neck cancer. Eur J Nucl Med Mol Imaging 34 (2007) 1953-1962